Highlights
NASDAQ: HTBX       Heat Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
1.16   -0.03 (2.52%)  1.11 - 1.23  350,909

Overview

 
Avg Volume (4 weeks):4,232,070
4 Weeks Range:1.11 - 1.42
4 Weeks Price Volatility (%):
16.13%
52 Weeks Range:0.195 - 4.30
52 Weeks Price Volatility (%):
23.51%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies which activate a patient’s immune system against cancer utilizing an engineered form of gp96. The group’s T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically-modified, irradiated human cancer cells which secrete tumor-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2784  2925  536  3157 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 OAS 0.155-0.014 
 NIO 30.165+2.655 
 NOK 3.325-0.725 
 PINS 68.425+19.175 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 GE 7.589+0.169 
 F 8.12+0.42 
 XOG 0.271-0.062